A therapeutic agent consisting of a monoclonal antibody linked to a toxin or drug. It is used to target, for example, a particular tumour in a patient. The antibody selectively binds to cancer cells expressing the corresponding antigen and is taken into the cell, where the toxin (e.g. ricin A chain) is cleaved, allowing it to kill the cell.